Lymphocyte-Activation Gene-3 Expression and Prognostic Value in Neoadjuvant-Treated Triple-Negative Breast Cancer

PURPOSE: In this study, we aimed to evaluate lymphocyte-activation gene-3 (LAG-3) expression and its prognostic value in neoadjuvant-treated triple-negative breast cancer (TNBC). METHODS: LAG-3, programmed death-1 (PD-1), programmed death ligand-1 (PD-L1), and CD8(+) tumor-infiltrating lymphocyte (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yunxuan, Dong, Tieying, Xuan, Qijia, Zhao, Hong, Qin, Ling, Zhang, Qingyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015973/
https://www.ncbi.nlm.nih.gov/pubmed/29963107
http://dx.doi.org/10.4048/jbc.2018.21.2.124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015973/
https://www.ncbi.nlm.nih.gov/pubmed/29963107
http://dx.doi.org/10.4048/jbc.2018.21.2.124

Ejemplares similares